Guna-diur Solution/ Drops
FDA Label NDC 17089-260

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Guna Spa for the product Guna-diur (NDC 17089-260). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1. indications and usage, 2. dosage and administration, 3. dosage forms and strengths, 4. contraindications, 5. warnings and precautions, 6. adverse reactions, 7. drug interactions, 8. use in specific populations, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

1. Indications And Usage


1.1.    Essential Hypertension (use with GUNA-MALE/FEM)
1.2.    Fluid retention (use with GUNA-PMS)
1.3.    Temporary weight gain (use with GUNA-MATRIX and GUNA-LYMPHO)
1.4.    Lymphedema (use with GUNA-LYMPHO)
1.5.    Tissue swelling
Administration may vary according to individual needs.
GUNA®-DIUR may be used together with other homeopathic medications

2. Dosage And Administration

The usual initial dose of GUNA®-DIUR is:

Adults and children 12 years and older                20 drops in a little water, 2 times per day
Children  between 12 years and 6 years of age    10 drops in a little water, 2 times per day
Children under 6 years                                         5 drops in a glass of water, 2 times per day

For an average of two months. If response is not satisfactory, add other products as suggested by your health care professional.

3. Dosage Forms And Strengths

3.1.    30 ml Bottle dropper.
3.2.    Each ingredient is attenuated according to the procedures stated in the Homeopathic Pharmacopeia of the United States. Amiloride 4x, Apis Mellifica 2x, Berberis Vulgaris T, Hydrochlorothiazide 4x, Hypophysis 12x, Mouse-Ear Hawkweed T, Solidago Virgaurea T, Spironolactone 4x.
Inactive Ingredient: Ethylic Alcohol 30%

4. Contraindications

4.1.    There is no history of hypersensitivity to GUNA®-DIUR. However patients with a known hypersensitivity to any GUNA®-DIUR ingredient should consult a physician prior to taking the medication

5. Warnings And Precautions

5.1.    GUNA®-DIUR is contraindicated in patients with anuria and in patients with a history of hypersensitivity to Spironolactone, Amiloride, or Hydrocholorthiazide.
5.2.    Use with caution in patients taking diuretic medications.

6. Adverse Reactions

6.1.    None known (see CONTRAINDICATIONS for hypersensitivity information).

7. Drug Interactions

7.1.    None Known

8. Use In Specific Populations

8.1.    Pregnancy:  Pregnancy  category  C.  Animal reproduction studies have not been conducted with GUNA®-DIUR.  GUNA®- DIUR should not be given to a pregnant woman. 
8.2.    Nursing mothers:    It is not known whether any of the ingredients in GUNA®- DIUR are secreted in human milk.  However, since many drugs are secreted in human milk, caution should be exercised when GUNA®- DIUR is administered to a nursing woman.
8.3.    Pediatric use: See DOSAGE AND AMINISTRATION.
8.4.    Geriatric use: No restrictions.

9. Drug Abuse And Dependence

9.1.    No Known.

10. Overdosage

10.1.    No Known.

11. Description

GUNA-DIUR is a biochemical homeopathic medication indicated for the treatment of fluid retention, swelling, essential hypertension, lymphedema, and related discomforts.

12. Clinical Pharmacology

12.1.    Mechanism of Action
The active ingredients in GUNA®- DIUR are simple biochemical compounds.   The exact mechanism of action is unknown; however, due to the homeopathic nature of the active ingredients, receptors may be activated by feedback regulation. 
12.2.    Pharmacodynamics
The physiological effects of GUNA®-DIUR are due to the action of the ingredients, as described in the Homeopathic Materia Medica.
In Homeopathy there is no direct relationship between dose and effect, but rather there is a relationship between attenuation and balancing effect on biochemical pathways.
In GUNA®-DIUR the attenuation of each ingredient has been selected according to Arndt-Schulz Principle (inverted effect law). The attenuation of the physiological ingredients promotes membrane receptor feedback in order to normalize altered biological pathways. In Addition the attenuation technique activates the low dilutions and stabilizes clinical activity of the compound.
12.3.    Pharmacokinetics
The homeopathic attenuation provides complete bioavailability of the active ingredients.

13. Nonclinical Toxicology

13.1.    GUNA®-DIUR has no level of toxicity due to the attenuation of the ingredients

14. Clinical Studies

14.1.    GUNA®-DIUR formulation is based on classical Homeopathy and each ingredient has been selected according to its description in the Homeopathic Materia Medica

15. References

15.1.    H.H. Reckeweg. Homeopathic Materia Medica.  Aurelia Verlag.
15.2.    Boericke,  William,  Materia  Medica  with  Reperatory,  1927,  ninth edition

16. How Supplied/Storage And Handling

16.1.    NDC  17089-260-18   Oral  Solution/Drops 30 mL16.2.    Store at room temperature, 20-25°C (68-77° F). Avoid  freezing  and  excessive  heat.

17. Patient Counseling Information

17.1.    Patients should be informed about Homeopathy and the main differences with conventional clinical approaches.

* Please review the disclaimer below.